Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine
Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.
Medical researchers have been trying to develop a vaccine for respiratory syncytial virus (RSV) for more than 50 years, without success. New findings by researchers at UC Santa Cruz, however, point to a promising route for designing an effective vaccine.
For most people, an RSV infection is just a bad cold, but for infants and older adults it can cause serious pneumonia or bronchial inflammation. In the 1960s, a traditional vaccine based on inactivated virus was found to actually make the disease worse. More recently, clinical trials of two different vaccines based on one of the viral surface proteins (the RSV F glycoprotein) have also failed.
The new study, published March 9 in Science Immunology, focused on the other major viral surface protein, the RSV G glycoprotein. Leveraging work by collaborators at Trellis Bioscience who have isolated protective human antibodies targeting the G glycoprotein, the UCSC researchers determined the atomic structure of RSV G and identified two sites on it that are targeted by protective antibodies effective against a broad range of RSV strains.
Corresponding author Rebecca DuBois, assistant professor of biomolecular engineering at UC Santa Cruz, said RSV G had been overlooked by vaccine researchers because initial studies found that deleting the gene for it didn't stop the virus from replicating in cell cultures. Studies in animal models, however, showed that virus lacking the G glycoprotein is significantly weakened.
"The G glycoprotein is actually very important," DuBois said. "It's the attachment protein that allows the virus to stick to lung cells, while the F glycoprotein promotes entry into the cell. Once the virus infects a cell and starts replicating, it makes a secreted form of the G glycoprotein that goes out and starts flipping switches on our immune cells, distorting our immune responses."
This disruption of the immune response by RSV G may explain why vaccines based on RSV F have failed, she said. "You need a protective antibody response that blocks that RSV G activity, but we didn't know how antibodies target RSV G at the molecular level."
In the new study, DuBois showed that these protective antibodies target a section of the protein called the central conserved domain that is the same in all strains of the virus. The researchers determined the three-dimensional atomic structures of the precise binding sites of two Trellis antibodies--crucial information for designing a vaccine that can induce the immune system to produce such protective antibodies.
"We're really excited about the possibility of finally being able to conquer this virus, which is one of the most important childhood viruses for which we don't have a vaccine," DuBois said.
In developing a vaccine based on RSV G, however, researchers would have to ensure that the vaccine lacks the viral protein's ability to disrupt the immune system. "There has been a lot of concern about making a vaccine with the G glycoprotein. We need to engineer it so that it can't subvert the immune system, while keeping its ability to elicit an effective antibody response," DuBois said.
Trellis Bioscience, meanwhile, is investigating the therapeutic use of the antibodies themselves to treat infants with RSV infection and severe lung congestion, with clinical trials expected to start in early 2019. If proven effective, the demand for a vaccine that elicits protective antibodies targeting the G glycoprotein will intensify, particularly for global use, DuBois said.
This article has been republished from materials provided by the University of California Santa Cruz. Note: material may have been edited for length and content. For further information, please contact the cited source.
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies. Stanislav O. Fedechkin, Natasha L. George, Jacob T. Wolff, Lawrence M. Kauvar and Rebecca M. DuBois. Science Immunology 09 Mar 2018: Vol. 3, Issue 21, eaar3534, DOI: 10.1126/sciimmunol.aar3534.
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Alternative to Antibiotics: Antibody Approach for Treating Multidrug-Resistant Bacterial InfectionsNews
Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide.READ MORE
Comments | 1 ADD COMMENT
bella weny | Mar 15, 2018
Do anyone still doubt natural herbs? I've seen the great importance of natural herbs and the wonderful work they have done in people's lives. I wonder why people still spend their money on surgery, injections and drugs each time they are sick. Natural herbs can cure all kinds of illness including herpes, diabetics, asthma, HIV, hepatitis, etc. I've seen it with my own eyes. I was cured of HIV and my aunt and her husband were cured of herpes by Dr. Abaka who uses natural herbs to cure different kind of illness.Dr. Abaka has prove to the world that natural herbs can cure all illness and he cured countless people using natural herbs. I know is hard to believe but am a living testimony. There is no harm trying herbs. He is also a spell caster, he cast spell to restore marriages back to normal, a good luck spell to prosper and excel in life. Contact Dr. Abaka email: firstname.lastname@example.org (phone/whatsap no): +2349063230051 https://drabakaspelltemple.wordpress.com.
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018